Food and Drug Administration (FDA) has issued warning letters to 30 telehealth companies citing false or misleading claims about compounded GLP-1 weight-loss products on their websites
This is true even if you have a current, valid prescription from your home country
As a nurse practitioner, the pressure of caring for people also played a part, especially during the pandemic
They're for people to inject. What side effects did you hear about from people taking unregulated peptides
In clinical studies, patients using GLP-1 medications experienced an average 15% reduction in total body weight, making it one of the most effective tools available for medical weight loss today
Legitimate access is limited to participation in authorised clinical trials or, if granted, MHRA early access mechanisms such as the Early Access to Medicines Scheme (EAMS) neither of which has been announced for retatrutide at this time